Design, synthesis, and biological evaluation of thioamide-linked spiropyrrolidine derivatives as novel 3CL(pro) inhibitors against SARS-CoV-2.

Guma SD, Song K, Sun H, Yang L, Zhou Z, Suo J, Bonku EM, Zheng W, Tian G, Jiang X, Zhang Q, Zhang Y, Shen J

Open source

DOI
10.1016/j.bmc.2025.118239
Published
2025 Oct 1
Container
Bioorganic & medicinal chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bmc.2025.118239,
  title = {Design, synthesis, and biological evaluation of thioamide-linked spiropyrrolidine derivatives as novel 3CL(pro) inhibitors against SARS-CoV-2.},
  author = {Guma SD and Song K and Sun H and Yang L and Zhou Z and Suo J and Bonku EM and Zheng W and Tian G and Jiang X and Zhang Q and Zhang Y and Shen J},
  year = {2025},
  journal = {Bioorganic \& medicinal chemistry},
  doi = {10.1016/j.bmc.2025.118239},
  url = {https://doi.org/10.1016/j.bmc.2025.118239}
}

RIS

TY  - JOUR
TI  - Design, synthesis, and biological evaluation of thioamide-linked spiropyrrolidine derivatives as novel 3CL(pro) inhibitors against SARS-CoV-2.
AU  - Guma SD
AU  - Song K
AU  - Sun H
AU  - Yang L
AU  - Zhou Z
AU  - Suo J
AU  - Bonku EM
AU  - Zheng W
AU  - Tian G
AU  - Jiang X
AU  - Zhang Q
AU  - Zhang Y
AU  - Shen J
PY  - 2025
JO  - Bioorganic & medicinal chemistry
DO  - 10.1016/j.bmc.2025.118239
UR  - https://doi.org/10.1016/j.bmc.2025.118239
ER  - 

APA

SD, G., K, S., H, S., L, Y., Z, Z., J, S., EM, B., W, Z., G, T., X, J., Q, Z., Y, Z., & J, S. (2025). Design, synthesis, and biological evaluation of thioamide-linked spiropyrrolidine derivatives as novel 3CL(pro) inhibitors against SARS-CoV-2.. Bioorganic & medicinal chemistry. https://doi.org/10.1016/j.bmc.2025.118239

Source records